Sunday, September 08, 2019 1:28:27 PM
$SNWV: 09/08/2019 UPDATED NEW DD PACK!! SEE THIS EXCITING US FDA CLEARED TECHNOLOGY---"FIRST AND ONLY" #FDA CLEARED TREATMENT FOR DIABETIC FOOT ULCERS USING SHOCKWAVE PRINCIPLES
ZACKS SMALL CAP RESEARCH
DermaPACE provides quick treatment for diabetes wounds
SANUWAVE LISTED AMONG AESTHETIC DEVICE MARKET GLOBAL LEADERS
SNWV SEC FILINGS
SNWV SECURITY DETAILS
SANUWAVE WEBSITE
SANUWAVE Company News
SANUWAVE ON TWITTER
SANUWAVE Accelerates Claims Coverage Expansion One Year Ahead of Expectations Due to Recent Positive Change in Reimbursement Coverage
SANUWAVE CAREERS--NOW HIRING
INVESTOR PRESENTATION DOWNLOAD
ZACKS SMALL CAP RESEARCH
DermaPACE provides quick treatment for diabetes wounds
SANUWAVE LISTED AMONG AESTHETIC DEVICE MARKET GLOBAL LEADERS
SNWV SEC FILINGS
SNWV SECURITY DETAILS
SANUWAVE WEBSITE
SANUWAVE Company News
SANUWAVE ON TWITTER
SANUWAVE Accelerates Claims Coverage Expansion One Year Ahead of Expectations Due to Recent Positive Change in Reimbursement Coverage
SANUWAVE CAREERS--NOW HIRING
INVESTOR PRESENTATION DOWNLOAD
Recent SNWV News
- Sanuwave Announces Revenues and Financial Results for Q1 FY2026 • GlobeNewswire Inc. • 05/12/2026 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 08:33:51 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2026 08:32:21 PM
- Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results • GlobeNewswire Inc. • 05/06/2026 09:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 08:05:14 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/04/2026 08:05:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/30/2026 08:10:03 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/29/2026 08:07:28 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/29/2026 08:06:41 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/29/2026 08:05:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 10:17:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/16/2026 09:05:51 PM
- Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-Year • GlobeNewswire Inc. • 04/16/2026 09:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:10:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:09:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:08:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:07:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:06:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 09:04:08 PM
- Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025 • GlobeNewswire Inc. • 03/26/2026 09:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 08:31:26 PM
- Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results • GlobeNewswire Inc. • 03/20/2026 05:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 08:33:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 09:04:10 PM

